期刊文献+

慢性阻塞性肺疾病患者血清晚期氧化蛋白产物水平变化的临床研究 被引量:3

Clinic study of serum product advanced oxidation protein changes of patients with chronic obstructive pulmonary disease
原文传递
导出
摘要 目的 检测慢性阻塞性肺疾病(COPD)患者血清晚期氧化蛋白产物(AOPP)的水平,探究AOPP与COPD的相关性及其临床意义.方法 纳入2011年4月至2013年11月来我院就诊的54例轻、中度COPD患者(COPD组);同期收集30名健康志愿者作为健康对照组,两组一般情况相匹配.分别检测血清AOPP、超氧化物歧化酶(SOD)和丙二醛(MDA)的水平.结果 健康对照组血清AOPP为(45.78±12.54) μmol/L、MDA为(2.96±0.55) μmol/L、SOD为(78.40±8.37) kU/L,COPD组血清AOPP为(68.93±10.62) μmol/L、MDA为(6.07±2.44) μmol/L、SOD为(53.66 ±5.99) kU/L,两组比较差异均有统计学意义(t值分别为-8.57、-9.14、14.38,P均<0.01).轻度COPD组患者血清AOPP为(65.56±9.65) μmol/L、MDA为(4.21±1.83) μmol/L、SOD为(62.97 ±6.28) kU/L,中度COPD组血清AOPP为(71.79±11.37) μmol/L、MDA为(7.43 ±3.12) μmol/L、SOD为(41.25 ±5.89) kU/L,两组比较差异均有统计学意义(t值分别为-2.17、-4.80、13.00,P<0.05或P<0.01).结论 血清AOPP水平增高是COPD患者的重要病理变化,可能参与COPD的发生及发展过程,是反映COPD患者氧化应激损伤的早期敏感指标. Objective To investigate the serum levels of advanced oxidation protein products (AOPP) in patients with chronic obstructive pulmonary disease (COPD) as well as explore the relevance of its clinical significance AOPP and COPD.Methods Fifty-four patients with mild/moderate COPD (COPD group) were enrolled in this study,who were treated in the No.100th Hospital of the Chinese People's Liberation Army from Apr.2011 to Nov.2013.Thirty healthy volunteers (control group) at same period were selected as control group and the general condition of two groups were matched.AOPP,superoxide dismutase(SOD) and malondialdehyde (MDA) levels were measured.Results The serum AOPP,MDA and SOD in control group were (45.78 ± 12.54) μmol/L,(2.96 ± 0.55) μmol/L and (78.40 ± 8.37) kU/L respectively.And its were (68.93 ± 10.62) μmol/L,(6.07 ± 2.44) μmol/L and (53.66 ± 5.99) kU/L respectively in COPD group.The differences were statistically significant (t =-8.57,-9.14,14.38 ; All P values were less than 0.01).The serum AOPP,MDA and SOD in mild COPD group were (65.56 ±9.65) μmol/L,(4.21 ± 1.83) μmol/L and (62.97 ± 6.28) kU/L respectively,and (71.79 ± 11.37) μmol/L,(7.43 ± 3.12) μmol/L and (41.25 ± 5.89) kU/L respectively in moderate CODP group.The differences were statistically significant (t =-2.17,-4.80,13.00; P < 0.05 or P < 0.01).Conclusion The increased levels of serum AOPP is important pathological changes in patients with COPD,which may be involved in the occurrence and development of COPD,and is the reaction of oxidative stress injury in patients with COPD early sensitive indicator.
出处 《中国综合临床》 2014年第11期1184-1187,共4页 Clinical Medicine of China
关键词 慢性阻塞性肺疾病 晚期氧化蛋白产物 超氧化物歧化酶 丙二醛 Chronic obstructive pulmonary disease Advanced oxidation protein products Superoxide dismutase Malondialdehyde
  • 相关文献

参考文献18

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264. 被引量:3859
  • 2Witko-Sarsat V, Friedlander M, Capeill:re-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia [J]. Kidney Int, 1996,49 (5):1304- 1313.
  • 3Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure [ J]. J Immunol, 1998, 161 (5) :2524-2532.
  • 4Witko-Sarsat V, Gausson V, Descamps-Latscha B. Are advanced oxidation protein products potential uremic toxins [ J]. Kidney Int Suppl,2003, (84) :S11-S14.
  • 5Kalousov6 M, Zima T, Tesar V, et al. Relationship between advanced glycoxidation end products, inflammatory markers/acute- phase reactants, and some autoantibodies in chronic hemodialysis patients[J]. Kidney Int Supp|,2003, (84) :$62-$64.
  • 6Liu SX, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation [ J ]. Arterioscler Thromb Vasc Biol,2006, 26(5) :1156-1162.
  • 7Skvarilov6 M, Bulava A, Stejskal D, et al. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome [J]. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub,2005,149( 1 ) :83- 87.
  • 8Selmeci L. Advanced oxidation protein products ( AOPP ) : novel uremic toxins, or components of the non-enzymatic antioxidant system of the plasma proteome [J]. Free Radic Res, 2011,45 (10) :1115-1123.
  • 9Piwowar A. The advanced oxidation protein products as potential diagnostic and prognostic factor in diseases of the indicated participation of oxidative stress [J]. Postepy Hig Med Dosw (Online) ,2014,68:446-458.
  • 10Chandramathi S, Suresh K, Anita ZB, et al. Comparative assessment of urinary oxidative indices in breast and colorectal cancer patients [ J ]. J Cancer Res Clin Onco1,2009,135 ( 2 ) :319-323.

二级参考文献37

共引文献3889

同被引文献38

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部